Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2008

View Archived Issues

Snapshots on the GlaxoSmithKline's antimalarial vaccines under clinical development in children

Recent clinical study results for anticoagulant DU-176b

Recent patents impart novel anticancer agents

TorreyPines describes new agents for Alzheimer's disease in recent patent

Dr. Reddy's patents novel antibacterial agents

Novocell and Pfizer enter collaboration for pancreatic progenitor cells derived from hES cells

Development of TPI-1020 in COPD discontinued

Oncolytics completes patient enrollment in REO-010 and REO-008 clinical trials of Reolysin

Pfizer and Celldex amend ACT III phase Ib/III clinical trial of CDX-110 in GBM

Genmab and GSK amend worldwide agreement to codevelop and commercialize Arzerra

AMAG receives complete response letter from FDA for ferumoxytol in kidney disease

TopoTarget reports further results from three phase II studies of NAD+ inhibitor APO-866

Phase II study of catumaxomab in gastric cancer meets primary endpoint

Evolva files CTA in Germany for phase I study of EV-077-3201-2TBS

BioCryst reports data for forodesine HCl in chronic lymphocytic leukemia

NPS commences phase III REPLACE study for NPSP-558 in hypoparathyroidism

Sanofi-aventis presents results from DIONYSOS trial in atrial fibrillation

AstraZeneca receives complete response letter for Seroquel XR for MDD

Northwest reports positive results from phase I/II clinical of DCVax-L in ovarian cancer

European Commission grants marketing authorization to Celgene's Vidaza in MDS and AML

Neuren discontinues Glypromate development following pivotal trial

Intercell initiates phase II trial for Pseudomonas aeruginosa vaccine

King commences phase II T-62 trial in neuropathic pain

Phase I study shows HA-22 highly active in hairy cell leukemia

Celsentri tablets approved in Japan for HIV

Addition of BSI-201 to gemcitabine/carboplatin feasible in triple negative breast cancer

Phase I and II data on trastuzumab-DM1 in HER2+ breast cancer reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...